March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
NCPA, NACDS welcome AMP hearing postponement
February 27th 2009The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) applauded a decision by U.S. District Judge Royce C. Lamberth to postpone a February hearing about Medicaid Average Manufacturer Price (AMP).